This announcement is a separate document:
派林生物:派林生物2023年度独立董事述职报告(王贤安 已离任)
Pacific Shuanglin Bio-pharmacy: Pailin Biotech's 2023 Independent Director Debriefing Report (Wang Xianan has left office)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.